藥物成份

共有 21645 個藥物成份

Betamethasone Valerate contains not less than 97.0% and not more than 103.0% of C27H37FO6, calculated on dried substance.

• 關聯藥證數量: 1

Betamethasone Valerate contains not less than 97.0% and not more than 103.0% of C27H37FO6, calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone Valerate contains not less than 97.0% and not more than 103.0% of C27H37FO6, calculated on the dried substance.

• 關聯藥證數量: 1

Betamethasone Valerate contains not less than 97.0%and not more than 103.0% of C27H37FO6,calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone contains 97.0% to 103.0% of C22H29FO5 (Dried substance)

• 關聯藥證數量: 1

Betamethasone contains not less than 97.0% and not more than 103.0% of C22H29FO5, calculated on the dried basis.

• 關聯藥證數量: 1

Betamethasone contains not less than 97.0% and not more than the equivalent of 103.0% of C22H29FO5 calculated on the dried substance.

• 關聯藥證數量: 1

Betamethasone dipropionate contains not less than 97.0% and not more than the equivalent of 103.0% of 9-fluoro-11β-hydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Betamethasone sodium Phosphate content not less than 96.0% and not more than 103.0% of C22H28FNa2O8P, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Betamethasone sodium phosphate contains not less than 96.0% and not more than the equivalent of 103.0% of 9-fluoro-11β, 17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-21-yl disodium phosphate, calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

Betamethasone valerate contains not less than 97.0% and not more than 103.0% of C27H37FO6, calculated on the dried substance.

• 關聯藥證數量: 1

Betamethasone valerate contains not less than 97.0% and not more than the equivalent of 103.0% of 9-fluoro-11b,21-dihydroxy-16b-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Betamethasone valerate contains not less than 97.0% and not more than the equivalent of 103.0% of C27H37FO6, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Betaxolol Hydrochloride contains not less than 98.5% and not more than 101.5% of C18H29NO3‧HCl, calculated on the dried substances.

• 關聯藥證數量: 1

Betaxolol Hydrochloride contains not less than 98.5% and not more than 101.5% of C18H30ClNO3 (dried substance).

• 關聯藥證數量: 1

Bethanechol Chloride contains not less than 98.0% and not more than 101.5% of C7H17ClN2O2, calculated on the anhydrous basis

• 關聯藥證數量: 1

Bethanechol Chloride contains not less than 98.0% and not more than 101.5% of bethanechol chloride (C7H17ClN2O2), calculated on the dried basis.

• 關聯藥證數量: 1

Bethanechol chloride contains not less than 98.0% and not more than 101.5% of C7H17ClN2O2, calculated on the dried basis.

• 關聯藥證數量: 1

Bezafibrate contains not less than 98.0% and not more than 102.0% of C19H20ClNO4 calculated on the dried basis.

• 關聯藥證數量: 1

Bezafibrate contains not less than 98.0% and not more than 102.0% of C19H20ClNO4, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Bezafibrate contains not less than 98.0% and not more than 102.0% of C19H20ClNO4,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Bictegravir Sodium

• 關聯藥證數量: 1

Bilastine (Form-I) contains not less than 98.0% and not more than 102.0% of C28H37N3O3, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bile Esculin Agar 43.5 g\n純水 1000 mL

• 關聯藥證數量: 1

Bilirubin : diazonium salt 3.1％Urobilinogen : diazonium salt 3.6％Ketones : sodium nitroprusside 2.0％Ascorbic acid : 2,6-dichlorophenolindophenol 0.7％Glucose : glucose oxidase 2.1％; peroxidase 0.9％; o-tolidine-hydroperoxidase 5.0％Protein : tetrabromophenol blue 0.2％Blood : tetramethylbenzidine-dihydrochloride 2.0％, isopropylbenzol- hydroperoxidase 21.0％pH : methyl red 2.0％; bromothymol blue 10.0％Nitrate : tetrahydrobenzo(h)quinoline-3-ol 1.5％; sulfanilic acid 1.9％Leukocytes : carboncylates 0.4％; diazonium salt 0.2％Specific Gravity : bromothymol blue 2.8％

• 關聯藥證數量: 1

Bilirubin is prepared from a bovine serumbase. Analyte levels are adjusted with bilirubin extracts and synthetic derivatives.

• 關聯藥證數量: 1

Bilirubin：0.4% w/w 2,4-dichloroaniline diazonium salt, balanced with buffer and non-reactive ingredients.Urobilinogen：2.9% w/w ρ-diethylaminobenzaldehyde balanced with buffer and nonreactive ingredients.

• 關聯藥證數量: 1

Bimatoprost 97.0%~103.0% (Dried basis)

• 關聯藥證數量: 1

Bimatoprost contains not less than 98.0 percent and not more than 102.0 percent of C25H37NO4 calculated on the anhydrous and solvent free basis.

• 關聯藥證數量: 1

Binary lite reagent : polyclonal goat anti-cTnI antibody (0.15 ug/mL) labeled with acridinium ester, 2 monoclonal mouse anti-cTnI antibodies labeled with biotin (2.0 ug/mL),in buffer with protein stabilizers and preservatives Solid phase : latex magnetic particles in buffer with protein stabilizers and preservativesAncillary reagent : non-magnetic latex particles in buffer with sodium azide (＜0.1%)Calibrator : after reconstitution, low or high levels of synthetic human BNP in lyophilized buffered sodium caseinate with sodium azide (＜0.1%)

• 關聯藥證數量: 1

Binding Buffer Reagent(R1): a buffer (pH 8.7at 25 ℃) containing 12.8 μmol/L Ferrous Ammonium Sulfate, surfactants.\nColor Reagent(R2): a solution containg 240 mmol/L Ascorbic Acid, 6.1 mmol/L Ferene.

• 關聯藥證數量: 1

Binding Reagent (1): 10 x 1 ml: Ethanol, water\nWash Reagent (2): 10 x 3.2 ml: Cysteamine HCl, EDTA (ethylenediaminetetraacetic acid), KCl, MTG (monothioglycerol), PEG (polyethyleneglycol), Sodium azide 0.05% w/v, Tris, pH 7.0, Tween-20, Water\nElution Reagent (3): 10 x 2.0 ml: Ammonium sulfate, EDTA (ethylenediaminetetraacetic acid), Sodium azide 0.05% w/v, Tris, pH 7.0, Water\nLysis Reagent (4): 10 x 300μl: N-acetyl-L-cysteine, Guanidine thiocyanate, N-lauroylsarcosine, Sodium citrate, pH 6.8, Water

• 關聯藥證數量: 1

Binimetinib

• 關聯藥證數量: 1

Biosite Triage TOX Drug Screen Panel, APAP & THC： Contains murine monoclonal antibodies and drug metabolites labeled with a fluorescent dye or immobilized on the solid phase, and stabilizers.Triage TOX Drug Screen Controls： Human urine matrix containing parent compounds and/or major metabolites/analogues of drugs of abuse.

• 關聯藥證數量: 1

Biotinlyated Link, Streptavidin-Enyme, endogeneous Enzyme Block, Chromogen, Antibody Diluent

• 關聯藥證數量: 1

Biperiden Hydrochloride contains not less than 98.0% and not more than 101.0% of C21H29NO‧HCl, calculated on the dried substance.

• 關聯藥證數量: 1

Biperiden Hydrochloride contains not less than 99.0% and not more than 101.0% of C21H30ClNO, calculated on the dried substance.

• 關聯藥證數量: 1

Bis-Tris-Propane, pH 7.4 25 mmol/l NADH 0.18 mmol/l Pyruvate 1.2 mmol/l Preservative

• 關聯藥證數量: 1

Bis/Tris Buffer 100 mmol/L \nCreatine Phosphate 31.5 mmol/L\nAMP 5.3 mmol/L\nNADP 2.2 mmol/L\nEDTA 2.1 mmol/L\nP1P5-diAP 10.3μmol/L \nMg2+ 10.5 mmol/L\nADP 2.7 mmol/L\nD-Glucose 21 mmol/L\nN-acetyl-l-cysteine 21 mmol/L\nHexokinase (yeast) > 3000 U/L\nG-6-PDH (leuconostoc) > 2000 U/L\npH 6.80 at 20°C\n

• 關聯藥證數量: 1

Bisacodyl contains not less than 98.0% and not more than 101.0% of C22H19NO4, calculated on the dried basis.

• 關聯藥證數量: 1

Bisbentiamine contains not less than 98.0% and not more than 102.0% of C38H42N8O6S2.

• 關聯藥證數量: 1

Bismuth Subcarbonate contains not less than 97.6 percent and not more than 100.7 percent of (BiO)2CO3 Calculated On The Dried Basis.

• 關聯藥證數量: 1

Bismuth Subcarbonate contains not less than 97.6% and not more than 100.7% of (BiO)2CO3, calculated on the dried basis.

• 關聯藥證數量: 1

Bismuth Subcarbonate contains not less than 97.6% and not more than 100.7% of (Bio)2CO3, calculated on the dried basis.

• 關聯藥證數量: 1

Bismuth Subnitrate contains not less than 71.0% and not more than 74.0% of Bi, calculated on the dried basis.

• 關聯藥證數量: 1

Bismuth Subnitrate contains not less than 79.0% of bismuth trioxide (Bi2O3), calculated on the dried basis.

• 關聯藥證數量: 1

Bismuth Subnitrate is a salt that contains the equivalent of not less than 79.0% of bismuth trioxide (Bi2O3), calculated on the dried basis

• 關聯藥證數量: 1

Bismuth subcarbonate contains not less than 80% and not more than 82.5% of (BiO)2CO3, calculated with reference to the dried basis.

• 關聯藥證數量: 1

Bismuth subgallate contains not less than 48% and not more than 51% of Bi(Ar 209.0),calculated with reference to the dried basis.

• 關聯藥證數量: 1

Bisoprolol Fumarate contains not less than 97.5% and not more than 102.0% of (C18H31NO4)2‧C4H4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bisoprolol Fumarate contains not less than 97.5% of (C18H31NO4)2？C4H4O4 calculated on anhydrous basis.

• 關聯藥證數量: 1

Bisoprolol Fumarate contains the equivalent of not less than 831ug of Bisoprolol (C18H31NO4) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bisoprolol Fumarate cotnains not less than 97.5% and not more than 102.0% of (C18H91NO4)2˙C4H4O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bisoprolol fumarate contains not less than 99.0 % and not more than 101.0 % of C40H66N2O12, calculated on anhydrous substance.

• 關聯藥證數量: 1

Biuret reagent\nSodium hydroxide 100 mmol/l\nNa-K-tartrate 16 mmol/l\nPotassium iodide 15 mmol/l\nCupric sulphate 6 mmol/l\nBlank reagent\nSodium hydroxide 100 mmol/l\nNa-K-tartrate 16 mmol/l\nStandard\nProtein 60 g/l (6.0 g/dl)

• 關聯藥證數量: 1

Bivalirudin contains not less than 95.0 percent and not more than 103.0 percent of C98H138N24O33 calculated on the anhydrous and trifluoroacetic acid free basis.

• 關聯藥證數量: 1

Blank.

• 關聯藥證數量: 1

Blend of polyviol alcohol 217, thymol and water

• 關聯藥證數量: 1

Bleomycin (sulfate)

• 關聯藥證數量: 1

Blood Clotting Accelerant-milk white spray, silicone dioxide 2.5% aqueous suspension 20 μl.\nSerum Separating Gel-light yellow, AP-TC polyolefine 0.6g (0.9g for ST740CG).

• 關聯藥證數量: 1

Blood Glucose Electrode:\nGlucose oxidase (Aspergillus niger)>=0.02 IU\nNon-reactive ingredients >=60ug

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-D (Anti-Rho) is a low- protein reagent prepared from human monoclonal IgM anti-D and human serum containing IgG anti-D.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-Fya is prepared from human blood containing appropriate antibodies, active by the indirect antiglobulin technique. The final formulation includes bovine albumin in a sodium chloride solution at a final total protein concentration within the range from 5 to 18%.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-Fyb is prepared from human blood containing appropriate antibodies, active by the indirect antiglobulin technique. The final formulation includes bovine albumin in a sodium chloride solution at a final total protein concentration within the range from 5 to 18%.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-JKa (clone MS15) is prepared from human/mouse heterohybridoma cell line secreting human IgM antibody and is designed for recognition of its corresponding antigen on human red blood cells.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-Jkb are prepared from human/mouse heterohybridoma cell lines secreting human IgM antibodies.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-k is prepared from human blood containing appropriate antibodies, active by the indirect antiglobulin technique.\nThe final formulation includes bovine albumin in a sodium chloride solution.Contains 0.1% sodium azide as a preservative.

• 關聯藥證數量: 1

Blood Grouping Reagent Anti-s prepared from human blood, active by the indirect technique.

• 關聯藥證數量: 1

Blood collection tubes contain EDTA anticoagulant.

• 關聯藥證數量: 1

Blood collection tubes contain Lithium Heparin & Polymer Gel.

• 關聯藥證數量: 1

Blood collection tubes contain anticoagulant sodium solution.

• 關聯藥證數量: 1

Blood grouping reagent Anti-Leb(LE2)(clone 4C4C7) are produced by murine hybridoma cell lines secreting specific IgM antibodies.

• 關聯藥證數量: 1

Blood: 6.6% w/w cumene hydroperoxide; 4.0% w/w 3,3’5,5’-tetramethylbenzidine;\n89.4% w/w buffer and nonreactive ingredients.\nProtein:0.3% w/w tetrabromophenol blue; 99.7% w/w buffer and nonreactive \ningredients.\n

• 關聯藥證數量: 1

Blood： 3,3’,5,5’-Tetramethylbenzidine 2.8mg, Cumene hydroperoxide 23.6mgBilirubin：sodium nitrite 0.733mgUrobilinogen：p-Dimethylaminobenzaldehyde 14.583mgKetones: Sodium nitroprusside 10.0mgProtein：tetrabromphenol blue 0.2mgNitrite：p-Arsanilic acid 2.7mgglucose: glucose oxidase 460 unit, peroxidase 2100 unit, potassium iodide 13.9mg pH：methyl red 0.03mg, bromthymol blue 0.5mgS.G.：Bromthymol blue 5.6mgleucocytes: naphtol AS-D chloroacetate 7.5mg, 2-chloro-4-benzamide-5-methylbenzenediazonium chloride 0.25mg.Ascorbic acid：2,6-Dichlorophenolindephenol 0.75mg, Methyl red 0.75mg

• 關聯藥證數量: 1

Blood：3, 3’,5,5’ –Tetramethylbenzidine 14.0mg, Cumene hydroperoxide 18.0mg\nBilirubin：2,4-Dichloroanilinediazoium 10.0mg\nUrobilinogen：p-Dimethylaminobenzaldehyde 75.0mg\nKetones：Sodium nitroprusside 150.0mg\nProtein：Tetrabromphenol blue 5.0mg\nNitrite：p-Arsanilic acid 17.5mg\nGlucose：Glucose oxidase 2300 unit, Peroxidase 10,500 unit, Potassium iodide 75.0mg\npH：Methyl red 2.5mg, Bromthymol blue 3.5mg\nLeucocytes：Naphtol AS-D chloroacetate 37.5mg, 2-chloro-4-benzamide-5-methylbenzenediazonium chloride 7.5mg\nAscorbic acid：2,6-Dichlorophenolindephenol 7.5mg, Methyl red 7.5mg

• 關聯藥證數量: 1

Blood：3,3’ ,5,5’–Tetramethylbenzidine 2.8 mg, Cumene hydroperoxide 23.6 mg, Bilirubin：Sodium nitrite 0.733 mg, Urobilinogen：p-Dimethylaminobenzaldehyde 14.583 mg, Ketones：Sodium nitroprusside 10.0 mg, Protein：Tetrabromphenol blue 0.2 mg, Nitrite：p-Arsanilic acid 2.7 mg, Glucose：Glucose oxidase 460 unit, Peroxidase 2100 unit, Potassium iodide 13.9 mg, pH：Methyl red 0.03 mg, Bromthymol blue 0.5 mg, S.G.：Bromthymol blue 5.6 mg, Leucocytes：Naphtol AS-D chloroacetate 7.5 mg, 2-chloro-4-benzamide-5-methylbenzenediazonium chloride 0.25 mg, Ascorbic acid：2,6-Dichlorophenolindephenol 0.75 mg, Methyl red 0.75 mg

• 關聯藥證數量: 1

Blue Latex Suspension Grouping A\nBlue Latex Suspension Grouping B\nBlue Latex Suspension Grouping C\nBlue Latex Suspension Grouping D\nBlue Latex Suspension Grouping F\nBlue Latex Suspension Grouping G\nExtraction Reagent 1\nExtraction Reagent 2\nExtraction Reagent 3\nPolyvalent Positive Control\nMixing Sticks\nLatex Test Cards

• 關聯藥證數量: 1

Boceprevir

• 關聯藥證數量: 1

Borax

• 關聯藥證數量: 1

Boric acid.....0.60w/v%\nSodium borate.....0.15w/v%\nHydroxyethylcellulose.....0.10w/v%\nTrehalose.....0.50w/v%\nSodium hyaluronate.....0.002w/v%\nDisodium edentate.....0.10w/v%\nSodium tetradecenesulfonate.....0.25w/v%\nTriethanolamine polyoxyethylene alkyl(12,13)ether sulphate.....1.00w/v%\nSodium hydroxide.....q.s.for pH adjustment\nHydrochloric acid.....q.s.for pH adjustment\nWater.....q.s. to 100%\n以下空白

• 關聯藥證數量: 1

Borine serum albumin 22%: prepared by fractionating bovine serum.

• 關聯藥證數量: 1

Bortezomib contains NLT 98.0% w/w and NMT 102.0% w/w of Bortezomib [C19H25BN4O4], calculated on dried basis.

• 關聯藥證數量: 1

Bortezomib Assay:97.0% to 103.0% on the anhydrous basis.

• 關聯藥證數量: 1

Bortezomib 98.0%~102.0% (Dried Basis)(最終含量範圍)

• 關聯藥證數量: 1

Bosentan monohydrate contains NLT 98.0% w/w and NMT 102.0% w/w of Bosentan monohydrate [C27H29N5O6S.H2O], calculated on anhydrous basis.

• 關聯藥證數量: 1

Both reagents contain stabilizers and a preservative.

• 關聯藥證數量: 1

Bottle Digoxin Concentration \n (ng/mL) (nmol/L)\nCAL A 0.0 0.00\nCAL B 0.5 0.64\nCAL C 1.0 1.28\nCAL D 2.0 2.56\nCAL E 3.0 3.84\nCAL F 4.0 5.12\n\nAxSYM Digoxin III Controls \n·3 Bottles (8 mL each) of AxSYM Digoxin III Controls contain digoxin prepared in recalcified human plasma, the following concentration ranges:\n\nBottle Digoxin Concentration Range\n (ng/mL) (nmol/L) (ng/mL) (nmol/L)\nCONTROL L 0.9 1.15 0.60 - 1.20 0.77 - 1.54\nCONTROL M 1.9 2.43 1.43 - 2.38 1.83 - 3.05\nCONTROL H 3.2 4.10 2.50 - 3.90 3.20 - 4.99\n

• 關聯藥證數量: 1

Bottle 1: Diluent.Bottle 1a: Antibody Reagent.Bottle 2: Microparticle Reagent.R1 Antibody Working Solution Secobarbital polyclonal antibody (sheep) in buffer, with bovine serum albumin, and preservative.R2 Microparticle Working Solution Conjugated secobarbital derivative microparticles in buffer and preservative

• 關聯藥證數量: 1

Bottle 1: Diluent、\nBottle 1a: Antibody Reagent、\nBottle 2: Microparticle Reagent、\nWorking solutions\nR1 Antibody Working Solution PCP monoclonal antibody (mouse) in buffer with bovine serum albumin and preservative.\nR2 Microparticle Working Solution Conjugated PCP derivative microparticles in buffer and preservative.

• 關聯藥證數量: 1

Bottle 1: Reagent;\nBottle 2: Reagent;\nBottle 3: Calibrator;\nBottle 4: Reagent\n

• 關聯藥證數量: 1

Boule Cal contains human red blood cells, mammalian and simulated white blood cells, and a platelet component in a preservative medium.

• 關聯藥證數量: 1

Boule Con Hematology Control contains treated, stabilized human erythrocytes and a stabilized platelet-sized component in an isotonic, bacteriostatic medium. Fixed erythrocytes are added to stimulate luckocytes.

• 關聯藥證數量: 1

Bovine Hemoglobin, Ethylenediaminetetraacetic acid (EDTA), Ethidium Bromide (EB), Acridine Orange (AO), plus several proprietary reagents.

• 關聯藥證數量: 1

Bovine Serum Albumin, Goat-anti-(Rabbit IgG) Polyclonal Antibody, Murine Anti a-hCG Polylonal Antibody, Murine Anti-B-hCG Monoclonal Antibody Colloidal Gold Conjugate, Rabbit IgG-Colloidal Gold Conjugate, Sodium Azide, Sodium Dibasic Phosphate, Sodium Chloride.

• 關聯藥證數量: 1

Bovine Serum Albumin, Goat-anti-Rabbit Antibody, Opiate-BSA Conjugate, Mouse Anti-Opiate Antibody, Rabbit IgG-Colloidal Gold Conjugate, Sodium Azide, sodium Dibasic Phosphate, Sodium Chloride.

• 關聯藥證數量: 1

Bovine Serum Albumin,Goat-anti-(Rabbit IgG) Polyclonal Antibody, Murine Anti-LH Monoclonal Antibody Colloidal Gold Conjugate, Rabbit IgG-Colloidal Gold Conjugate, Murine Anti-LH Antibody, Sodium Azide, Sodium Dibasic Phosphate, Sodium Chloride.

• 關聯藥證數量: 1

Bovine Serum Albumin\nCarbamazepine\nPhenobarbital\nPhenytoin\nTheophylline\nValproic Acid

• 關聯藥證數量: 1

Bovine Thrombin 100NIH (#50502:10 x 2 mL or #50555: 10 x 5 mL), \nImidazole Buffered saline (#50504: 2 x 135 mL)\nNormal coagulation Control (#50100: 10 x 1 mL)\nHemostasis Reference Plasma, Abnormal (#50721: 10 x 1 mL)

• 關聯藥證數量: 1

Bovine serum albumin

• 關聯藥證數量: 1

Bovine serum albumin suitable quantity ; Each analytes suitable quantity

• 關聯藥證數量: 1